Views From The Leaf

The Summit Releaf Blog

Post-Traumatic Stress Disorder

January 6, 2020

Post-Traumatic Stress Disorder

Post-Traumatic Stress Disorder (PTSD) is a psychological health response after an individual has gone through a traumatic event. A traumatic event can be classified as anything, ranging from sexual assault, warfare, traffic accidents, and child abuse. The symptoms associated with PTSD can range from disturbing thoughts, feelings, or dreams associated with the event. Mental or physical distress to trauma-related cues, attempts to avoid trauma-related cues, alterations in how a person thinks and feels, and an increase in the fight-or-flight response are also symptoms when diagnosed with PTSD. Symptoms associated with PTSD usually last for a month or longer after the event. These symptoms manifest differently in young children who are less likely to show distress. Typically, young children will express their memories through play and other activities. Unfortunately, people living with PTSD are at higher risk to do self-harm and are more likely to commit suicide.

Counseling is the best method to combat a PTSD diagnosis. However, counseling may not be effective when provided to all trauma-exposed individuals whether or not symptoms are present. Still, the best methods of treating PTSD are counseling and medication. Antidepressants, typically, are the first lines of defense when diagnosed with PTSD, and oftentimes, results in a beneficial outcome for about half of all people. When counseling and medication are used together, the outcomes are much better for those who are suffering from PTSD. 3.5% of people live with PTSD in the United States and 9% of people develop it at some point in their life. Throughout the world, people living with PTSD usually hover around 1%, depending on the rates during a given year. Of course, higher rates may occur in areas where there is armed conflict. After the Vietnam War and into the 1970s, PTSD became an official diagnosis after it was officially recognized by the American Psychiatric Association in 1980.

Medical marijuana can play a major role in helping to battle the adverse reactions of PTSD. Many researchers believe that cannabis may dampen the strength or emotional impact of traumatic memories through synergistic mechanisms that might make it easier for people with PTSD to rest or sleep and to feel less anxious and less involved with flashback memories. Also, the evidence is mounting that supports cannabis can help with fear extinction and anti-depressive effects. Through a variety of small clinical trials, the use of individual cannabinoids has shown to have great success in PTSD treatment. In a trial of ten subjects, the adjunctive administration of orally absorbable THC (tetrahydrocannabinol) caused a statistically significant improvement in global symptom severity, sleep quality, frequency of nightmares, and PTSD hyperarousal symptoms. Nabilone, a synthetic cannabinoid, has been proven in clinical trials to safely mitigate various symptoms of post-traumatic stress, including insomnia, chronic pain, and treatment-resistant nightmares.

PTSD is a qualifying condition for medical marijuana in Ohio and patients that suffer from this diagnosis can come to Summit Releaf for a consultation to obtain their Ohio marijuana card. At Summit Releaf we make it as easy as possible to obtain your Ohio marijuana card, by offering discounts to those members of our community who receive social security or are US veterans that served honorably. Some of the more effective marijuana strains that help with the symptoms of PTSD are Blue Dream (sativa), OG Kush (hybrid), Pineapple Express (hybrid), Master Kush (sativa), and Cannatonic (hybrid).

The following information is presented for educational purposes only. Summit Releaf provides this information to provide an understanding of the potential benefits of medical marijuana for patients living with one of the approved Ohio Medical Marijuana Control Program qualifying conditions. Links to third party websites do not constitute an endorsement of these organizations by Summit Releaf and none should be inferred.